PSI6206

CAS No. 863329-66-2

PSI6206( GS-331007 | RO 2433 )

Catalog No. M16249 CAS No. 863329-66-2

PSI-6206 (RO2433) is a selective HCV RNA polymerase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 In Stock
25MG 53 In Stock
50MG 72 In Stock
100MG 102 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PSI6206
  • Note
    Research use only, not for human use.
  • Brief Description
    PSI-6206 (RO2433) is a selective HCV RNA polymerase inhibitor.
  • Description
    PSI-6206 (RO2433) is a selective HCV RNA polymerase inhibitor.
  • In Vitro
    PSI-6206 (RO 2433) is tested for anti-HCV activity in both a cell-based quantitative real-time RT-PCR assay and surrogate bovine viral diarrhea virus (BVDV) assays. PSI-6206 demonstrates no activity or cytoxicity in any assay. The formation of the 5′-triphosphate (TP) of PSI-6130 (PSI-6130-TP) and RO2433 (RO2433-TP) increases with time and reached steady state levels at 48 h. RO2433-TP also inhibits RNA synthesis by the native HCV replicase isolated from HCV replicon cells and the recombinant HCV polymerase NS5B. PSI-6206 (RO2433) is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase.
  • In Vivo
    ——
  • Synonyms
    GS-331007 | RO 2433
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    HCV replicon
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    863329-66-2
  • Formula Weight
    260.22
  • Molecular Formula
    C10H13FN2O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C1NC(C=CN1[C@@H]2O[C@H](CO)[C@@H](O)[C@]2(F)C)=O
  • Chemical Name
    1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyl-tetrahydrofuran-2-yl)pyrimidine-2,4-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. ClarkJeremy L, et al. J. Med. Chem., 2005, 48 (17), pp 5504-5508
molnova catalog
related products
  • Coblopasvir

    Coblopasvir (KW136, KW-136) is a novel HCV NS5A inhibitor under development for treatment of HCV infection.

  • 4-Phenoxybenzylamine

    4-Phenoxybenzylamine inhibits the function of the NS3 protein by stabilizing an inactive conformation with an IC50 of about 500 μM against HCV NS3/4a .

  • Uprifosbuvir

    A novel uridine nucleotide analog HCV NS5B polymerase inhibitor for treatment of HCV infection combined with Grazoprevir and Ruzasvir.